Cargando…
Different decay of antibody response and VOC sensitivity in naïve and previously infected subjects at 15 weeks following vaccination with BNT162b2
BACKGROUND: COVID-19 vaccines have demonstrated effectiveness in reducing SARS-CoV-2 mild and severe outcomes. In vaccinated subjects with SARS-CoV-2 history, RBD-specific IgG and pseudovirus neutralization titers were rapidly recalled by a single BTN162b2 vaccine dose to higher levels than those in...
Autores principales: | Siracusano, Gabriel, Ruggiero, Alessandra, Bisoffi, Zeno, Piubelli, Chiara, Carbonare, Luca Dalle, Valenti, Maria Teresa, Mayora-Neto, Martin, Temperton, Nigel, Lopalco, Lucia, Zipeto, Donato |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8742572/ https://www.ncbi.nlm.nih.gov/pubmed/34998405 http://dx.doi.org/10.1186/s12967-021-03208-3 |
Ejemplares similares
-
SARS-CoV-2 vaccination elicits unconventional IgM specific responses in naïve and previously COVID-19-infected individuals
por: Ruggiero, Alessandra, et al.
Publicado: (2022) -
Serology study after BTN162b2 vaccination in participants previously infected with SARS-CoV-2 in two different waves versus naïve
por: Dalle Carbonare, Luca, et al.
Publicado: (2021) -
CRISPR/Cas system: An emerging technology in stem cell research
por: Valenti, Maria Teresa, et al.
Publicado: (2019) -
Control of the Autophagy Pathway in Osteoarthritis: Key Regulators, Therapeutic Targets and Therapeutic Strategies
por: Valenti, Maria Teresa, et al.
Publicado: (2021) -
Antibody response in individuals infected with SARS-CoV-2 early after the first dose of the BNT162b2 mRNA vaccine
por: Gobbi, Federico, et al.
Publicado: (2021)